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SUMMARY. Disease surveillance is vital to the management of New Zealand’s endemic and threatened avian species. Three
infectious agents that are potential threats to New Zealand’s endemic birds include avian polyomavirus (APV), beak and feather
disease virus (BFDV), and avian malaria. All three agents have been reported in New Zealand; however, possible reservoir
populations have not been identified. In this communication, we report the first study of APV, BFDV, and avian malaria in
introduced adult exhibition budgerigars (Melopsittacus undulatus) in New Zealand. Blood samples were collected from 90 living
adult budgerigars from three breeding locations in the North Island of New Zealand. An overall APV prevalence of 22% was
determined using a broad-spectrum nested PCR that amplified the major capsid protein VP1 gene of polyomavirus. Phylogenetic
analysis of the VP1 gene revealed a unique isolate of APV, which had a sequence divergence of 32% to previously reported
budgerigar fledgling disease strains and 33% to the recently reported New Zealand finch isolate. All of the budgerigars sampled
were found to be PCR negative for BFDV, and an overall prevalence of 30% was detected by PCR for avian malaria. Sequencing
revealed the presence of ubiquitous malarial strains and also the potentially destructive Plasmodium relictum strain. The results of
this study suggest that both APV and avian malaria are present in New Zealand adult budgerigars, and our study highlights the
need for further studies to determine whether these pathogens in captive bird populations may be a threat or spill over into New
Zealand’s endemic and threatened avifauna and whether prevention and control methods need to be implemented.
RESUMEN. Un estudio de enfermedades de tres poblaciones reproductoras de periquitos australianos (Melopsittacus undulatus)
de exhibicio´n en Nueva Zelanda revela una alta prevalencia de una infeccio´n por un nuevo poliomavirus y por la malaria aviar.
La vigilancia de enfermedades es vital para el manejo de las especies aviares ende´micas y amenazadas de Nueva Zelanda. Tres
agentes infecciosos que son amenazas potenciales para las aves ende´micas de Nueva Zelanda incluyen al poliomavirus aviar (APV),
el virus de la enfermedad del pico y plumas (BFDV), y la malaria aviar. Los tres agentes se han reportado en Nueva Zelanda, sin
embargo, no han sido identificadas poblaciones de posibles reservorios. En este artı´culo se presenta el primer estudio de
poliomavirus aviar, del virus del pico y las plumas y de la malaria aviar en periquitos australianos (Melopsittacus undulatus) adultos
de exhibicio´n introducidos a Nueva Zelanda. Se recolectaron muestras de sangre de 90 periquitos adultos vivos de tres lugares de
crı´a en la Isla Norte de Nueva Zelanda. Se determino´ una prevalencia general de poliomavirus aviar de 22% utilizando un me´todo
de PCR anidado que amplifica el gene de la proteı´na principal de la ca´pside VP1 del poliomavirus. El ana´lisis filogene´tico del gene
VP1 revelo´ un aislamiento u´nico de poliomavirus, que tenı´a una divergencia de 32% en su secuencia en comparacio´n con las cepas
previamente asociadas con la enfermedad de la muda francesa de los periquitos (budgerigar fledgling disease) y de un 33% con un
aislamiento de pinzo´n de Nueva Zelanda reportado recientemente. Todos los periquitos muestreados resultaron ser negativos por
PCR para la enfermedad del pico y las plumas, y se detecto´ una prevalencia general del 30% por PCR para la malaria aviar. La
secuenciacio´n revelo´ la presencia de cepas de malaria ubicuas y de una cepa de Plasmodium relictum que es potencialmente
destructiva. Los resultados de este estudio sugieren que tanto poliomavirus aviar y la malaria aviar esta´n presentes en periquitos
australianos adultos de Nueva Zelanda y ponen de manifiesto la necesidad de realizar ma´s estudios para determinar si estos
pato´genos presentes en poblaciones de aves en cautiverio pueden ser una amenaza o puedan extenderse a las especies ende´micas y
fauna aviar amenazada de Nueva Zelanda y si se requieren aplicar me´todos de prevencio´n y control.
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Polyomaviruses are members of the Polyomavirus genus with
nonenveloped virons encapsidating circular double-stranded DNA
genome (28). These viruses have been shown to infect a wide range
of avian and mammalian host species, although most have been
shown to be species specific (26). Avian polyomavirus (APV) was
first discovered in 1981 (10) and is known to be the causative agent
in budgerigar fledgling disease (33) as well as causing fatal disease in
a variety of other species (5,15,16,27,30). APV affects a range of
avian hosts; however, the clinical presentation, distribution of
lesions, and epidemiological effects of the virus on a population vary
markedly between susceptible species (5,10,13). PolyomavirusECorresponding author. E-mail: L.Howe@massey.ac.nz
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infection in birds is an acute inflammatory disease and can have a
mortality rate of up to 100% in fledglings (28). To date, there are
five known polyomaviruses of birds; APV, goose hemorrhagic
polyomavirus (GHPV), finch polyomavirus (FPyV), crow poly-
omavirus (CPyV), and canary polyomavirus (CaPyV) (20).
In budgerigars (Melopsittacus undulatus), the severity of disease
caused by APV depends on the age and condition of the bird when
exposure occurs. Clinical presentation includes acute death at 10–
15 days old with no clinical signs, while other fledglings may develop
abdominal distension, subcutaneous hemorrhage, ataxia, hydroperi-
cardium, ascites, and feather abnormalities known as ‘‘French molt’’
(10,22,28,33,37,47). APV has also been associated with decreased
hatchability and embryonic death (17). As a result of several
devastating outbreaks in captive birds in North America, Australia,
and Europe, APV is now a recognized globally as an avian pathogen
(43). A small serological survey in 2002 (25) and a recent confirmed
report of APV isolated by PCR from a captive finch (1) suggests that
this virus is present in New Zealand; however, the prevalence in
caged and wild birds is unknown.
A second common viral disease causing feather loss in psittacine
birds is beak and feather disease virus (BFDV), a member of the
family Circoviridae. The virus is highly infectious, and all psittacine
birds are potentially susceptible to BFDV infections, which cause
progressive feather loss, dystrophy, and beak deformities (40,44).
The virus was first described in psittacine birds in the Australia (36)
and is now the most important infectious disease affecting psittacine
species. The virus has been detected in New Zealand native parrots
(Cyanoramphus spp. [two species] and Platycercus eximius)
(18,19,32,34) and is considered to be the cause of high mortality
rates in the South African cape parrot (Poicephalus robustus) and
lovebirds (Agapornis spp.) (53).
Finally, avian malaria is a mosquito-borne disease caused by
intracellular parasites in the order Haemosporida, genus Plasmodi-
um. Species of the genus Plasmodium have a cosmopolitan
distribution and can infect nearly all avian taxa (51). Passerines
are known to be hosts to the largest number of haemosporidian
parasites (51). For example, Plasmodium relictum has a global
distribution and has long been known to infect blackbirds (Turdus
merula) and other introduced birds in New Zealand (24,50), which
are commonly observed as asymptomatic carriers of avian malaria,
showing a low mortality and mainly chronic parasitaemia of
malaria (50). Recent studies in New Zealand have shown
Plasmodium spp. are able to infect a wide range of endemic
avifauna and have been diagnosed as causing death in threatened
species such as dotterel (Charadrius obscurus) (2), South Island
saddleback (Philesturnus carunculatus carunculatus) (4), mohua
(Mohoua ochrocephala) (3), hihi (Notiomystis cincta) (3), brown kiwi
(Apteryx mantelli) (7), and great spotted kiwi (Apteryx haastii) (24).
Although they are not notifiable diseases in New Zealand, APV,
BFDV, and Plasmodium spp. are still considered ‘‘diseases of
concern’’ in conservation management (54); however, detailed
information on the three diseases is limited, particularly within the
captive bird populations. The last legal importation of budgerigars
into New Zealand occurred in 1996; the birds are now maintained
as a ‘‘closed population.’’ Thus, these birds provide a unique
opportunity to identify possible pathogens within the breeding
populations and their role as disease reservoirs for New Zealand’s
threatened endemic avifauna. In this preliminary study, we report
the identification of a novel polyomavirus possibly associated with
observed feather abnormalities and four different avian malaria
strains infecting adult exhibition budgerigars in three breeding
collections in the North Island of New Zealand.
MATERIALS AND METHODS
Sample collection. Thirty budgerigars were sampled from each of
three breeding aviaries in the North Island of New Zealand in July 2012.
We selected aviaries where budgerigars were bred and where feather
abnormalities had occurred within the last 3 yr. All three aviaries had
exchanged and exhibited birds at the same shows in the last 2 yr.
Bird captures were carried out using a 2-mm woven nylon hand bird
net with a 200-mm padded wire frame on a 500-mm polyester handle.
Band numbers were recorded for every sampled bird, and the birds were
examined for feather condition, evidence of skin lesions, external injury,
and general body condition. Where possible, birds with feather
abnormalities were selected. Feathers were regarded as abnormal if
on physical examination, any feathers were missing, dystrophic, or
otherwise imperfect. Once appropriately restrained in hand, a blood
sample of 0.1 ml was collected from the jugular vein of each bird using
0.33-mm (29G) needle on a BD Ultra-FineTM 0.5-ml insulin syringe
(Becton, Dickson and Company, Franklin Lakes, NJ) following
protocols described by Brown (11). Blood was spotted onto two pieces
of grade one filter paper (WhatmanTM; GE Healthcare, Little Chalfont,
Buckinghamshire, UK) and dried before being placed into a mini snap-
lock bag. To avoid cross contamination between samples, gloves were
disposed of between each bird, and the capture net was soaked in a
disinfectant solution (VirkonS, Dupont, Wilmington, DE) for 10 min
between samples. Samples were stored at room temperature until
processed.
Blood smear preparation and microscopy. A single drop of blood
from each bird sampled was used to produce a thin blood smear that was
air-dried, placed in a slide holder at the time of collection, and
subsequently stained with Diff-Quick. Each blood smear was examined
to determine the differential white cell count (WCC), smears were
examined under a light microscope for a minimum of 15 min, initially
at low power (3400) for 10 random fields of single layered red blood
cells. All white cells were counted and recorded; the sum of white cells
from all 10 fields was divided by 5 to give an estimated mean differential
white cell count. Smears were then examined at 31000 under oil
immersion and a breakdown of the white cell population was recorded
by scanning each slide until 100 white cells were observed.
Molecular detection of APV. DNA was isolated from each sample
using the DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA)
following the manufacturer’s protocol for nucleated whole blood. The
presence of the polyomavirus major capsid protein VP1 gene was
identified using a broad-spectrum nested PCR as described by Johne et
al. (26). To confirm successful amplification, 10 ml of the final PCR
product was run on a 1.5% agarose gel containing ethidium bromide
prior to purification and sequencing. A known polyomavirus positive
tissue sample from a Gouldian finch (1), confirmed by sequencing was
used as a positive control, and water blanks were included as negative
controls.
Two positive PCR amplicon samples from each aviary were purified
using a PureLink PCR purification kit (Invitrogen, Carlsbad, CA) and
subjected to automatic dye-terminator cycle sequencing with BigDyeTM
Terminator Version 3.1 Ready Reaction Cycle Sequencing kit and the
ABI3730 Genetic Analyzer (Applied Biosystems Inc., Foster City, CA)
to confirm genomic sequence using both the forward and reverse
primers. The polyomavirus isolate sequences obtained were compared by
NCBI Blast to other published sequences available from GenBank.
Phylogenetic analysis of polyomavirus isolates. The VP1 gene from
one sequence of bovine papillomavirus (bovine PapV) and 19
representative polyomaviruses detected in different bird and mammal
species submitted to GenBank, three polyomaviruses isolated in this
study (NZBPyV3, 90, 78), and the outgroup bovine papillomavirus
were trimmed to the same length (282 base pairs) using GeneiousTM
(Biomatters, Auckland, New Zealand) and aligned using Clustal W (23)
with gaps ignored. A Bayesian phylogenetic tree was generated in
MrBayes version 3.1 (46) using general time-reversible model including
invariable sites (GTR+I) as a nucleotide substitution model. The
Bayesian phylogeny was obtained using one cold and three hot Monte
Carlo Markov chains, which were sampled every 1000 generations over
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1.5 million generations. Of these trees, 25% were discarded as burn-in
material. The remaining trees were used to construct a majority
consensus tree. Bootstrap percentages from the Bayesian analysis were
added to the tree at the appropriate nodes. Pairwise identities between
and within the different strains were calculated with species demarcation
tool (SDT) v1.0.
Open reading frames were identified, and amino acid sequences were
deduced from the nucleotide sequences from five previously described
avian polyomaviruses (CaPyV GenBank GU345044, APV GenBank
AF241168, FPyV GenBank DQ192571, GHPV GenBank AY140894,
CPyV GenBank DQ192570) and an isolate from this study
(NZBPyV3) using Geneious (Biomatters) and aligned using Clustal
W (23). The sequence divergence between and within the different
strains was calculated using SDT v1.0.
Molecular detection of BFDV. Total DNA was extracted from
blood and feather budgerigar samples using iGenomic blood DNA
extraction kit (Intron Biotechnology, Sangdaewon-Dong, South Korea)
according to the manufacturer’s instructions. A BFDV screen was set up
using primers that target a ,600-bp region of the replication associated
gene (59-TTA ACA ACC CTA CAG ACG GCG A-39 and 59-GGC
GGA GCA TCT CGC AAT AAG-39) (45). In brief, 4 ml of the total
extracted DNA was used in a PCR reaction with the above primers and
KAPA Blood PCR Kit Mix B (KAPA Biosystems, Woburn, MA) using
the following protocol: an initial 5-min denaturation step, followed by
25 cycles of 94 C for 30 sec, 56 C for 30 sec, and 72 C for 45 sec, with a
final extension step of 72 C for 1 min and cooling to 4 C for 10 min for
renaturation. The amplicons were resolved on a 1% agarose gel stained
with SYBRH Safe DNA stain.
Molecular detection of Avian Malaria. DNA was extracted from
whole blood as described for the detection of APV. The presence of the
cytochrome b gene of Plasmodium spp. was identified using a nested PCR
and the nested primer sets HaemNF1/HaemNR3 and HaemF/HaemR2
as described by Hellgren et al. (21). To confirm a successful
amplification, 10 ml of the final PCR product was run on a 1.5%
agarose gel containing ethidium bromide prior to purification and
sequencing. A known Plasmodium spp.–positive blood sample was used
as a positive control, and water blanks were included as negative
controls. Three representative Plasmodium spp.–positive PCR amplicon
samples from each property were purified and subjected to sequencing
as described above. Chromatograms were examined for conspicuous
overlapping peaks suggestive of Plasmodium spp. coinfection. The
Plasmodium isolate sequences obtained were compared with the MalAvi
database (9) and by NCBI Blast with those other published sequences
available from GenBank.
Animal Ethics. Samples were obtained under permission of the
collection owners and the University of Queensland Animal Ethics
Committee (Production and Companion Animal) permit number SVS/
106/12.
Statistics. The relationships between APV and avian malaria were
examined, as was each of these and their relationship with common
disease indicators in budgerigars. Disease indicators examined included
endoparasite and ectoparasite load, mean differential white cell count,
age, and feather abnormalities. A combination of Pearson’s chi-squared
test, Wilcoxon analysis, and two sample t-tests were used to determine
statistical significance for each of the relationships. All analyses were
carried out using the R programming language for statistical computing
(39). Tests were carried out at the 5% level of significance. Specifically,
the relationship between APV and mean differential WCC was
examined using a loge transformation of WCC to normalize the data
set and a two sample t-test. Results are presented exponentiated back
into the original units (3 109 cells/L) and refer to group medians, rather
than means, as a consequence of this transformation.
RESULTS
Clinical and molecular evidence of polyomavirus infection.
Sixty-six percent (60/90) of the sampled birds had clinical evidence
of flight feather or tail abnormalities; this included primary flight
feather loss ranging from one flight feather unilaterally, to all flight
feathers bilaterally. Tail feather abnormalities included primary and
secondary feather loss or feathers that remained ensheathed. The
remainder of the birds sampled displayed normal feather character-
istics.
Twenty-two percent (20/90) of blood samples were found to be
positive for the polyomavirus VP1 gene (Table 1). Each of the
properties sampled had birds with polyomavirus positive blood
samples. Among the birds with normal plumage, the prevalence
ranged between 14.3 and 26.7% (Table 1). Birds with feather
abnormalities had a prevalence of between 11.1 and 28.6%
(Table 1). There was no statistical difference between the detected
polyomavirus prevalence in the birds displaying normal plumage
versus abnormal plumage (P 5 0.37). Of the common disease states
examined, there was a strong relationship between infection with
APV and an increased estimated differential mean WCC. Median
WCC was 8.0 (95% confidence interval [CI] 5 6.7–9.6)3 109/L in
polyomavirus positive birds compared with 15.4 (95% CI 5 10.7–
22.3) 3 109/L in noninfected birds, P 5 0.001. We estimate the
median white cell count for birds infected with APV to be 1.93
(95% CI 5 1.30–2.86) times higher (or 93% larger) than birds
without the virus. These findings indicate a leucocytosis, which is
frequently a sign of an inflammatory response, most commonly the
result of infection, but also observed in certain parasitic infections.
BLAST analysis of six isolates showed a range of sequence
homology (69–81%) with budgerigar fledgling disease polyoma-
virus APV strains (GenBank GU452537, DQ304718, AF241168,
AB453160), 71% homology with goose hemorrhagic (GHPV) and
nonhemorrhagic polyomavirus strains (GenBank HQ681903,
AF226991), and 72% homology with a New Zealand finch poly-
omavirus isolate (NZFPyV1, GenBank JX425365). All other well-
characterized polyomavirus strains, including human (GenBank
JX262162), bat (GenBank JQ958889), and northern fur seal
(GenBank JQ031271) isolates, had a sequence homology ranging
between 67 and 91%. In most cases, high sequence homology with
nonavian polyomavirus strains only covered 30% or less of the
submitted sequence, whereas the polyomavirus strains aligned to
Table 1. Summary of polyomavirus PCR results and comparison with birds displaying normal feathers and abnormalities.
Property 1 Property 2 Property 3
TotalNormalA AbnormalB Normal Abnormal Normal Abnormal
Number of samples 9 21 0 30 21 9 90
Polyomavirus positive sample 2 6 0 8 3 1 20
Prevalence (%) 22.2 28.6 0 26.7 14.3 11.1 22.2
95% confidence interval 2.8–60.0 11.3–52.2 0 12.3–45.9 3.0–36.3 0.3–48.2 14.1–32.2
ANumber of birds with normal feather plumage.
BNumber of birds with feather abnormalities.
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97% of the submitted sequence, suggesting that the New Zealand
isolates were novel budgerigar strains and were tentatively designated
NZ budgerigar polyomavirus (NZBPyV).
Phylogenetic analysis confirmed the novel nature of the NZBPyV
isolates but did cluster them with the representative APV (GenBank
AF241168) and FPyV (GenBank DQ192571) strains consistent
with the avian host (Fig. 1). Sequence divergence analysis showed a
30% and 31% difference between the NZ isolates and the APV and
FPyV strains, respectively, consistent with the BLAST results. A
separate alignment of the partial VP1 sequence (89 amino acids) of
the five known bird polyomaviruses and the NZ isolates were
suggestive of a relatively high amino acid divergence (25.8–36%),
particularly in the H-I loop (Fig. 2).
Molecular detection of BFDV and avian malaria. None of the
90 individual samples tested were positive for BFDV; however, the
prevalence of avian malaria varied between properties and ranged
between 13% and 43% with an overall prevalence of 30% (Table 2).
Twenty-six percent of birds positive for Plasmodium spp. DNA were
also positive for APV, although this relationship was not statistically
significant (P 5 0.6701). Sequencing of three representative positive
samples from each property revealed differences in the Plasmodium
spp. infecting the birds (Table 2). Two of three isolates from
property 1 had 100% sequence homology to the reference strain of
Plasmodium (Huffia) elongatum GRW6 (GenBank DQ368381).
The third isolate had 99% sequence homology to the reference
strain of Plasmodium (Haemamoeba) relictum GRW4 (GenBank
AY099041). In addition, all three isolates sequenced from property 2
and two isolates from property 3 displayed 100% sequence homology
to Plasmodium spp. lineage AFTRU5 (GenBank DQ847263), and
the final isolate from property 3 had 100% sequence homology with
P. (Novyella) spp. lineage SYATO5 (GenBank DQ847271). No
evidence of mixed infections (conspicuous overlapping peaks) was
observed in the isolates sequenced.
DISCUSSION
Disease surveillance is vital to the management of New Zealand’s
endemic and threatened avian species. In some instances, potential
pathogens can infect bird species without causing disease, while in
others the infection results in high levels of mortality. In addition,
subclinical disease in some hosts, particularly introduced species,
Fig. 1. Phylogenetic analysis of polyomavirus isolated from exhibition budgerigars (Melopsittacus undulatus) in New Zealand. Bayesian analysis
of a 282 nucleotide fragment of the VP1 gene from 1 sequence of bovine papillomavirus (bovine PapV) and 19 polyomaviruses detected in different
bird and mammal species submitted to GenBank, and three representative polyomaviruses isolated in this study (in bold). The tree is rooted on a
lineage of bovine papillomavirus. Numbers above the branches indicate bootstrap support based on 1000 replicates. Host species and GenBank
accession numbers of the sequences are given after the abbreviated polyomavirus names.
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may provide a reservoir population for subsequent infection of naive
endemic avifauna. Three infectious agents that are potential threats
to New Zealand’s endemic birds include APV, BFDV, and avian
malaria. All three agents have been reported in New Zealand;
however, the possible reservoir populations have not been identified
for APV and BFDV.
As the first study examining budgerigars as a possible reservoir
population, the implications are far reaching. Not only have we
confirmed APV is present in at least some New Zealand budgerigar
aviaries, but the identification of a novel virus suggests that more
detailed phylogenetic and phylogeographical studies are needed to
improve our understanding of APV in birds in New Zealand.
Further investigation is warranted into the presence and effects of
APV in captive populations of native New Zealand psittacine parrots
including kakariki (Cyanoraphus sp.) and zoological collections of
kea (Nestor notabilis) and kaka (Nestor meridionalis).
Most budgerigars become infected with APV as nestlings, and
survivors shed the virus in their droppings for up to 6 mo
postinfection (38). The budgerigars sampled in this study included
fledglings and adults between 6 mo and 6 yr old, with PCR positive
birds between 9 mo and 5 yr 8 mo old, which suggest that this novel
strain of APV is enzootic in all three aviaries sampled. A study by
Ritchie et al. (42) suggests that budgerigars are the only avian species
that remain persistently infected and shed the virus throughout life.
However, another study suggested that APV can be eliminated from
aviaries by resting seropositive adult birds from breeding 7 mo prior
to breeding, leading to the production of seronegative, clinically
normal budgerigar chicks (38).
Our study suggests that there may be an association with
polyomavirus and leukocytosis. Interestingly, there was no statistical
support for the association between APV and avian malaria infection
or feather abnormalities. The latter may have been the result of a
stringent selection criterion for feather abnormalities, in that any
abnormal, missing, or dystrophic feathers meant the bird was
considered abnormally feathered for analysis purposes. Including
naturally molting birds missing flight or tail feathers is therefore a
potential source of bias, but by the nature of the selection criteria,
this could not have been avoided without a complicated feather
grading system. Importantly, BFDV can be excluded as a potential
source of feather loss in the budgerigars sampled, and the 0% (95%
CI 5 0.0–4.0%) prevalence in birds selected for clinical feather
abnormalities makes it unlikely BFDV is a major viral pathogen
affecting budgerigar collections in New Zealand.
Having established the presence of APV in New Zealand, it is
important to now attempt to better understand its epidemiology
and, more specifically, the possible risks associated with APV to
native New Zealand psittacine birds. Most members of the
Polyomaviridae family are limited in their host range. In contrast,
APV appears to be infective in a wide variety of Psittaciformes,
Passeriformes, and gallinaceous birds (41). The wide variety of
clinical manifestations previously recorded between species and the
potential for dissemination into avian species outside of the
budgerigar aviaries in which it appears enzootic suggests that this
novel polyomavirus poses an unknown, but potentially significant
risk to the native avifauna population in New Zealand. Combined
with the lack of investigation into the potential effects on a naive
population and the unknown susceptibility of New Zealand’s native
bird species, this suggests that APV should be an area of high
importance with regard to maintaining and conserving New
Zealand’s native and endemic avifauna.
An example of how rapidly these introduced diseases can spread is
avian malaria. Up until 50 yr ago, Plasmodium infections in native
and endemic New Zealand birds were considered uncommon (29).
However, over the last decade avian malaria has become increasingly
common and has caused mortality in several threatened species,
including the mohua (M. ochrocephala) (3), North Island brown kiwi
(A. mantelli) (24), and South Island saddleback (P. carunculatus
carunculatus) (4). The prevalence of Plasmodium in introduced
passerines ranges between 7% and 100% depending on region, time
of year, and avian species sampled (48,50). In native passerines, the
prevalence of chronic infections has been recorded as 10%–13% in
North Island saddleback (Philesturnus carunculatus) and bellbirds
(Athornis melanura), respectively (6,12). Phylogenetic analysis of
Plasmodium species present in New Zealand native and endemic
birds includes the internationally ubiquitous P. (Huffia) elongatum
and the potentially devastating P. (Haemamoeba) relictum
(12,14,24), both of which were isolated in this study.
This study found at least four different strains of Plasmodium
circulating in the budgerigar populations of New Zealand’s North
Island. The high incidence of infection in the birds sampled suggests
Fig. 2. Alignment of the deduced amino acid sequences of VP1 from the six known bird polyomaviruses. The 239–328 amino acid region of the
VP1 is shown and identical positions with the sequence are indicated by a dot. The VP1 HI loop is boxed (according to Liddington et al.) (31).
Table 2. Summary of BFDV and avian malaria PCR results and Plasmodium spp. detected by sequencing.
Property
number BFDV positive (%)
Plasmodium PCR
positive (%)
No. of Plasmodium positive
birds coinfected with APV (%) Plasmodium lineages identified GenBank no.
1 0/30 (0) 4/30 (13) 2/4 (50) P. (Huffia) elongatum GRW6 DQ368381
P. (Haemamoeba) relicitum GRW4 AY099041
2 0/30 (0) 10/30 (30) 2/10 (20) Plasmodium spp. AFTRU5 DQ847263
3 0/30 (0) 13/30 (43) 3/13 (23) P. (Novyella) spp. SYATO5 DQ847271
Plasmodium spp. AFTRU5 DQ847263
Total 0/90 (0) 27/90 (30) 7/27 (26)
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that the infectious cycle is well established in these collections.
Plasmodium (Huffia) elongatum has been reported in a wide range of
avian orders but particularly Passeriformes, which are thought to act
as reservoirs (51). Similarly, both Plasmodium spp. AFTRU5 and
P. (Novyella) spp. SYATO5 are considered ubiquitous in most
Passeriformes in New Zealand, with P. (Novyella) spp. SYATO5
showing a predilection for the blackbird (T. merula) (24). It is
important to note that an isolate of P. (Haemamoeba) relictum GRW4
was detected in one of the collections. This particular strain of
Plasmodium is widespread throughout Europe and tropical regions of
Africa and known to be a host generalist with a cosmopolitan
distribution (51). Lineages GRW4 and SGS1 have been shown to infect
multiple African and European avian host species, which suggests that
members of the P. (Haemamoeba) relictum subgenera undergo relatively
frequent host shifts (21,52). Notably, the ability to host shift may have
contributed to the decline and extinction of bird species in Hawaii after
the introduction of lineage GRW4 (8). Plasmodium (Haemamoeba)
relictum has been shown experimentally to infect various passerines with
differing disease severity (35). While there was no relationship between
common disease indicators and Plasmodium spp. infection in the
budgerigars sampled, further longitudinal modeling is warranted to
determine the significance and pathogenicity of the various strains in
budgerigars. Budgerigar collections may also act as a point source
reservoir for infection of those birds that frequent the environment in
which the budgerigars live. These wild birds have the potential to then
disseminate Plasmodium spp. large distances either through migration
events or normal home range movements, which, assuming there is a
suitable vector in the environment, will facilitate spread to naive, native
populations.
This is the first study to demonstrate the presence of APV and
avian malaria in breeding populations of New Zealand exhibition
budgerigars. Thus, a thorough examination of the interaction
between these diseases and the budgerigar population will increase
our understanding of the prevalence and potential impact avian
malaria may be having on our endangered and threatened avifauna.
An increasing awareness and regular monitoring programs of
introduced and endemic avian species will help to develop
appropriate management strategies for conservation programs to
minimize the impact of these diseases in New Zealand.
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